[1]
Nandiwardhana, A., Suwanto, D., Mulia, E.P.B., Nugraha, D., Lefi, A., Budiarto, M. and Nugroho, J. 2022. Dexamethasone and olmesartan as potential antiremodelling agents of valvular interstitial cell into myofibroblast. International journal of health sciences. 6, S9 (Aug. 2022), 379–391. DOI:https://doi.org/10.53730/ijhs.v6nS9.12283.